找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: HDL Metabolism and Diseases; Lemin Zheng Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Na

[复制链接]
楼主: abandon
发表于 2025-3-23 11:38:30 | 显示全部楼层
The Future of Risk Management, Volume IIC, while it is also claimed that CETP weakens atherosclerosis formation by promoting RCT. Currently, the CETP-related drugs are still immature. Research on CETP inhibitors is targeted at improving efficacy and minimizing adverse reactions. As for CETP agonists, research has proved that they also can be used to resist atherosclerosis.
发表于 2025-3-23 17:52:01 | 显示全部楼层
发表于 2025-3-23 20:28:48 | 显示全部楼层
发表于 2025-3-24 00:27:11 | 显示全部楼层
https://doi.org/10.1007/978-1-349-20369-7lipoprotein (HDL) particles, and ABCG1 facilitates subsequent continued cholesterol efflux to HDL for further maturation. In this chapter, we summarize the roles of ABCA1 and ABCG1 in maintaining cellular cholesterol homoeostasis and discuss the underlying mechanisms by which they mediate cholesterol export.
发表于 2025-3-24 04:31:42 | 显示全部楼层
发表于 2025-3-24 06:55:42 | 显示全部楼层
发表于 2025-3-24 13:03:33 | 显示全部楼层
HDL and Endothelial Function,ial functions, lots of cardiovascular diseases such as atherosclerosis could not be fully prevented and treated. Thus, a further understanding of the relationship between HDL and endothelial cell is needed, which would create a potential therapeutic approach to cardiovascular diseases.
发表于 2025-3-24 16:43:06 | 显示全部楼层
发表于 2025-3-24 21:23:18 | 显示全部楼层
ABCA1, ABCG1, and Cholesterol Homeostasis,lipoprotein (HDL) particles, and ABCG1 facilitates subsequent continued cholesterol efflux to HDL for further maturation. In this chapter, we summarize the roles of ABCA1 and ABCG1 in maintaining cellular cholesterol homoeostasis and discuss the underlying mechanisms by which they mediate cholesterol export.
发表于 2025-3-25 03:12:19 | 显示全部楼层
HDL and Therapy, apolipoprotein mimetic peptides like apoA-I and and apoE mimetics have undergone clinical assessment, and we have also reviewed the advances of clinical trials and gave an outlook for the therapy of rHDL and mimetic peptides.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 01:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表